Dr. Reddy's News
Most Popular Dr. Reddy's Story
Dr. Reddy's make risky biogenerics move
At the Motley Fool, Brian Orelli analyzes a recent decision by India-based generic drug developer Dr. Reddy's Laboratories to spend $20 million to produce eight new generic versions of biologics over the next eight years.
Read more...Latest Headlines
- January 4, 2010
- May 21, 2009
- April 24, 2008
- March 10, 2008
- March 3, 2008
- February 5, 2008
- January 22, 2008
- October 25, 2007
- September 25, 2007
- June 29, 2007
- July 16, 2006
- March 1, 2006
- February 15, 2006
- February 2, 2006
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
